Copyright
©The Author(s) 2015.
World J Gastroenterol. Jan 28, 2015; 21(4): 1222-1233
Published online Jan 28, 2015. doi: 10.3748/wjg.v21.i4.1222
Published online Jan 28, 2015. doi: 10.3748/wjg.v21.i4.1222
Table 2 Postoperative adjuvant treatment protocols n (%)
| Treatment | Follow up (yr) | Total (n = 201) | P value1 | |
| Before 2008 (n = 127) | 2008-2010 (n = 74) | |||
| Chemoradiotherapy | 84 (66.1) | 63 (85.1) | 147 (73.1) | 0.023 |
| Chemotherapy | 19 (15.0) | 6 (8.1) | 25 (12.4) | |
| Supportive treatment | 10 (7.9) | 2 (2.7) | 12 (6.0) | |
| None (follow up) | 14 (11.0) | 3 (4.1) | 17 (8.5) | |
| Radiotherapy | 0.003 | |||
| No | 43 (33.9) | 11 (14.9) | 54 (26.9) | |
| Yes | 84 (66.1) | 63 (85.1) | 147 (73.1) | |
| Chemotherapy protocol | < 0.001 | |||
| FUFA | 70 (55.1) | 42 (56.8) | 112 (55.7) | |
| CEF | 9 (7.1) | 21 (28.3) | 30 (14.9) | |
| None | 14 (11.0) | 3 (4.1) | 17 (8.5) | |
| UFT | 23 (18.1) | 1 (1.4) | 24 (11.9) | |
| TCF | 1 (0.8) | 5 (6.8) | 6 (3.0) | |
| Supportive | 10 (7.9) | 2 (2.7) | 12 (6.0) | |
| Type of radiotherapy device | < 0.001 | |||
| Co60 | 21 (25.3) | 0 (0.0) | 21 (14.4) | |
| Linak | 58 (69.9) | 7 (11.1) | 65 (44.5) | |
| Varian-Siemens | 4 (4.8) | 56 (88.9) | 60 (41.1) | |
| Simulator planning | < 0.001 | |||
| 2 dimensional | 79 (62.7) | 7 (9.5) | 86 (43.0) | |
| 3 dimensional | 4 (3.2) | 56 (75.7) | 60 (30.0) | |
| No radiotherapy | 43 (34.1) | 11 (14.9) | 54 (27.0) | |
- Citation: Ozden S, Ozgen Z, Ozyurt H, Gemici C, Yaprak G, Tepetam H, Mayadagli A. Survival in gastric cancer in relation to postoperative adjuvant therapy and determinants. World J Gastroenterol 2015; 21(4): 1222-1233
- URL: https://www.wjgnet.com/1007-9327/full/v21/i4/1222.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i4.1222